Close

Soligenix, Inc. (SNGX) to Advance Synthetic Hypericin Development in Psoriasis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI
6. LRCX
7. BIIB
8. F
9. CNMD
10. BSX


Go back to Soligenix, Inc. (SNGX) to Advance Synthetic Hypericin Development in Psoriasis
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $4.35 
Open $0.38    52 Week Low $0.44 
Day High $0.38    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 55,350